We are pleased announce the new “Share” an article feature on the Current Oncology website. This feature allows our readers to share links to our arti

 
CO-NEWSLETTER-LOGO August
ESMO-Web-Banner560x100
***

We are pleased announce the new “Share” an article feature on the Current Oncology website. This feature allows our readers to share links to our articles through their social media outlets including Facebook, Twitter, LinkedIn, Reddit, ResearchGate and CiteULike. Look for the “Share” icon at the bottom of the abstract, PDF and HTML pages of each article.

ShareArticlesIcon

We encourage authors to use this new tool to promote their work to a wider audience and help expand the reach and impact of their research. We also encourage our readers to share articles they feel are relevant to their colleagues and peers.

Are you looking for other ways to connect with Current Oncology? We encourage you to follow us on Twitter to receive immediate updates regarding the journal, and the latest in Canadian oncology research. Follow us @CurrentOncology.

logo70

Multimed Inc.
Publisher of Current Oncology
www.multi-med.com

***
CO Twitter Banner Ad
***
InPress-CON

Volume 22, Number 4 (August 2015)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:
http://www.current-oncology.com/index.php/oncology/issue/current/showToc

CO-COVER-ISSUE

Highlights from this issue...

Ready or not? Lung cancer diagnosis in 2015
K. Jao, C. Labbe,N.B. Leighl

Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?
R. VanderMeer,S. Chambers, A. Van Dam, J.C. Cutz, J.R. Goffin, P.M. Ellis

Enhancing access to cancer care for the Inuit
P. Doering, C. DeGrasse

A retrospective review of cancer treatments and outcomes among Inuit referred from Nunavut
T.R. Asmis, M. Febbraro, G.G. Alvarez, J.N. Spaans, M. Ruta, A. Lalany, G. Osborne, G.D. Goss

An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT
C.T. Kouroukis, M. Crump, D. MacDonald, J.F. Larouche, D.A. Stewart, J. Johnston, S. Sauvageau, E. Beausoleil, P. Sage, S.G. Dubois, A. Christofides, S. Di Clemente, L. Sehn

***
LookingAhead-CON

Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 22, Number 5 (October 2015) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:
http://www.current-oncology.com/index.php/oncology/about/futureTOC

***
ImpactFactor2014
***
EditorSpotlight
Head shot 2

Jason Park, MEd, MD, FRCRC, FACS
Editor of our Oncology Education Section (since May 2013)

Dr. Jason Park completed medical school at the University of Toronto followed by a residency in General Surgery at the University of Manitoba. He went on to complete a clinical Fellowship in Surgical Oncology at the renowned cancer centre Memorial Sloan-Kettering in New York City. Dr. Park also holds a Master’s Degree in Education from the University of Toronto.
Dr. Park is a Surgical Oncologist at St. Boniface General Hospital and CancerCare Manitoba in Winnipeg, Manitoba. He is also an Associate Professor in the Section of Surgical Oncology at the University Manitoba. His clinical focus is surgery for complex colon and rectal cancers, as well as laparoscopic colorectal surgery, and GI endoscopy. In addition to his position with Current Oncology, he also serves as an Associate Editor for the Canadian Journal of Surgery.


***
HaveYouHeard-CON

No Authors Fees for Clinical Research and Clinical Trial Articles: Until Dec 31, 2015

560x100 Banner

Current Oncology is seeking high-quality original clinical research and clinical trial articles. Areas may include research related to treatment, prevention, diagnostic, screening, and quality of life. Articles submitted should contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine.

To help encourage submissions, Current Oncology will waive Standard Author Fees for all original clinical research and clinical trial articles, submitted between July 1st and December 31st, 2015.

View our full announcement for more details.

Call for Original Canadian Cancer Costing Research: Submission Due Date Sept 30, 2015

Current Oncology will be publishing a special supplemental issue dedicated to "Original Canadian Cancer Costing Research". This supplement will be co-edited by Dr. Nicole Mittmann (Cancer Care Ontario, Toronto, Ontario) and Dr. Claire de Oliveira (Centre for Addiction and Mental Health, Toronto, Ontario).

Submissions to the Current Oncology supplement can include studies for any cancer using regional, provincial or national data sources, to evaluate any one of the following themes:

• Burden of illness studies;
• Costs of interventions, programs and policies;
• Applied costing studies;
• Direct costs borne by patient or other payers;
• Indirect costs around lost earnings and/or productivity;
• Population health modeling studies;
• Studies adapting models for the Canadian context.

Studies using data from clinical, administrative or survey sources can be submitted in which patient, health care system or societal perspectives are considered.

Visit our website for more details on how to submit your manuscript for this special issue.

***
ReadersChoice-COn

Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (July 2015)

Legalizing euthanasia or assisted suicide: the illusion of safeguards and controls
Pereira J.
Curr Oncol. 2011 Apr;18(2):e38-45

Management of arthralgias associated with aromatase inhibitor therapy
Thorne C.
Curr Oncol. 2007 Dec;14 Suppl 1:S11-9

Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature
Salvo N, Barnes E, van Draanen J, Stacey E, Mitera G, Breen D, Giotis A, Czarnota G, Pang J, De Angelis C.
Curr Oncol. 2010 Aug;17(4):94-112

Most Read Recently* Published Articles at www.current-oncology.com

A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults
Seftel MD, Barnett MJ, Couban S, Leber B, Storring J, Assaily W, Fuerth B, Christofides A, Schuh AC.
Curr Oncol. 2014 Oct;21(5):234-50. doi: 10.3747/co.21.2183

Bortezomib in multiple myeloma: systematic review and clinical considerations
Kouroukis TC, Baldassarre FG, Haynes AE, Imrie K, Reece DE, Cheung MC
Curr Oncol. 2014 Aug;21(4):e573-603. doi: 10.3747/co.21.1798

Management of hypersensitivity to platinum- and taxane-based chemotherapy: CEPO review and clinical recommendations
Boulanger J, Boursiquot JN, Cournoyer G, Lemieux J, Masse MS, Almanric K, Guay MP, and the Comité de l’évolution des pratiques en oncologie
Curr Oncol. 2014 Aug;21(4):e630-41. doi: 10.3747/co.21.1966

*Published within past 12 months

***
CO-NEWS-MEETINGALERT
OE-logo-98x60

Please Join Us for the 2015 ESMO Summit Americas!

OncologyEducation.com is pleased to present The ESMO Summit Americas: Oncology Updates — From Evidence to Practice, an official ESMO® Summit Meeting, a program licensed by the European Society for Medical Oncology. This international meeting will highlight the most significant, practice-changing data to emerge from the European Society of Medical Oncology's Annual Conference (ESMO 2015) and put it into context for an anticipated audience of more than 200 oncology professionals from across the Americas.

The ESMO Summit Americas is a three-day event with presentations focused on several key disease sites. As part of the conference, several panel-type symposia will also be organized, with focus on integrating the evidence into clinical practice for key tumour sites and to address regional differences in practice and patient management guidelines.

Early-Bird Pricing Available, Register Today!

Visit our 2015 ESMO Summit Americas Webpage for More Details

***
300 x 80px-01
ImportantAnnouncement

GRANT FUNDING: Making Cancer Less Painful for Kids

CKN is very excited to report that in partnership with Drs. Christine Chambers and Jennifer Stinson and many others, our Canadian Cancer Society grant “Cancer Pain Assessment and Management in Children: Using Social Media to Bridge the Gap” has been funded!

Children with cancer experience pain, often prolonged, over the course of their treatment. Considerable research supports evidence-based approaches to pain assessment and management among children with cancer. Yet knowledge to action gaps in addressing children’s cancer pain are well documented. Many children with cancer do not benefit from access to evidence-informed pain care. Knowledge translation efforts to improve pain care for children have primarily targeted health professionals, yet parents are also key knowledge users of evidence about children’s pain and can serve as powerful pain management advocates.

The goal of this grant is to increase parent awareness and use of evidence-based knowledge about children’s cancer pain. The research team and CKN will develop, implement, and evaluate an integrated social media campaign called “Making Cancer Less Painful For Kids”. The partnership will capitalize on CKN’s well-established reach and engagement via their website, e-newsletter, and social media.

We look forward to working with this amazing group of childhood cancer advocates on this very special project. Stay tuned....

***
QuickLinks-CON
***

Contact Us

Email-CON
 
Address-CON
 
Phone-CON
 
Web-CON
twitter
1px